These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25903833)

  • 21. Hydrophobic Nanoparticles Reduce the β-Sheet Content of SEVI Amyloid Fibrils and Inhibit SEVI-Enhanced HIV Infectivity.
    Sheik DA; Chamberlain JM; Brooks L; Clark M; Kim YH; Leriche G; Kubiak CP; Dewhurst S; Yang J
    Langmuir; 2017 Mar; 33(10):2596-2602. PubMed ID: 28207276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.
    Sanchez MD; Ochoa AC; Foster TP
    Antiviral Res; 2016 Aug; 132():13-25. PubMed ID: 27192555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Semen-derived enhancer of viral infection--a key factor in sexual transmission of HIV].
    Duan JM; Qiu JY; Tan SY; Liu SW; Li L
    Bing Du Xue Bao; 2012 Jan; 28(1):84-8. PubMed ID: 22416356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of semen-derived amyloid (SEVI) on sperm viability and motility: its implication in male reproductive fitness.
    Kumar V; Kumar PG; Yadav JK
    Eur Biophys J; 2019 Oct; 48(7):659-671. PubMed ID: 31392382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses.
    Qiu M; Li Z; Chen Y; Guo J; Xu W; Qi T; Qiu Y; Pang J; Li L; Liu S; Tan S
    Front Microbiol; 2020; 11():504. PubMed ID: 32425892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.
    Roan NR; Münch J; Arhel N; Mothes W; Neidleman J; Kobayashi A; Smith-McCune K; Kirchhoff F; Greene WC
    J Virol; 2009 Jan; 83(1):73-80. PubMed ID: 18945786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
    Elias AK; Scanlon D; Musgrave IF; Carver JA
    Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen.
    Easterhoff D; Ontiveros F; Brooks LR; Kim Y; Ross B; Silva JN; Olsen JS; Feng C; Hardy DJ; Dunman PM; Dewhurst S
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2443-50. PubMed ID: 23507280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts.
    Van Dis ES; Moore TC; Lavender KJ; Messer RJ; Keppler OT; Verheyen J; Dittmer U; Hasenkrug KJ
    Virology; 2016 Jan; 488():88-95. PubMed ID: 26609939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI).
    Elias AK; Wilson MR; Carver JA; Musgrave IF
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
    Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J
    Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide nanofibrils as enhancers of retroviral gene transfer.
    Meier C; Weil T; Kirchhoff F; Münch J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(5):438-51. PubMed ID: 24865496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host nectin-1 is required for efficient Chlamydia trachomatis serovar E development.
    Hall JV; Sun J; Slade J; Kintner J; Bambino M; Whittimore J; Schoborg RV
    Front Cell Infect Microbiol; 2014; 4():158. PubMed ID: 25414835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen.
    Usmani SM; Zirafi O; Müller JA; Sandi-Monroy NL; Yadav JK; Meier C; Weil T; Roan NR; Greene WC; Walther P; Nilsson KP; Hammarström P; Wetzel R; Pilcher CD; Gagsteiger F; Fändrich M; Kirchhoff F; Münch J
    Nat Commun; 2014 Apr; 5():3508. PubMed ID: 24691351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus.
    Angelova M; Ortiz-Meoz RF; Walker S; Knipe DM
    J Virol; 2015 Aug; 89(16):8474-83. PubMed ID: 26041297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication.
    Botting C; Lu X; Triezenberg SJ
    Virol J; 2016 Jan; 13():15. PubMed ID: 26817608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual concentration-dependent effect of ascorbic acid on PAP(248-286) amyloid formation and SEVI-mediated HIV infection.
    Mohapatra S; Viswanathan GKK; Wettstein L; Arad E; Paul A; Kumar V; Jelinek R; Münch J; Segal D
    RSC Chem Biol; 2021 Oct; 2(5):1534-1545. PubMed ID: 34704058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication.
    Kucera LS; Leake E; Iyer N; Raben D; Myrvik QN
    AIDS Res Hum Retroviruses; 1990 May; 6(5):641-7. PubMed ID: 1972888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
    Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
    PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection.
    Capule CC; Brown C; Olsen JS; Dewhurst S; Yang J
    J Am Chem Soc; 2012 Jan; 134(2):905-8. PubMed ID: 22239120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.